Table 1.
Urokinase group | Urokinase + tirofiban group | P | ||
---|---|---|---|---|
Sex (male/female) | 4/3 | 4/6 | – | 0.637 |
Age (years) | 64.71 ± 10.48 | 58.50 ± 9.03 | 1.308 | 0.211 |
High blood pressure (n/%) | 6/85.71 | 8/80.00 | – | 1.000 |
Diabetes (n/%) | 2/28.57 | 2/20.00 | – | 1.000 |
Blood glucose at admission (mmol/L) | 10.43 ± 6.45 | 8.96 ± 3.51 | 0.608 | 0.552 |
Low density lipoprotein (mmol/L) | 2.58 ± 1.12 | 3.38 ± 0.93 | –1.601 | 0.130 |
OTT (h) | 3.31 ± 0.87 | 3.05 ± 1.40 | 0.431 | 0.673 |
OTT: onset to treatment time. Qualitative data are expressed as rates and were compared using the chi-squared or Fisher’s exact test; quantitative data were compared using the Mann–Whitney U test.